Author: Amy Brenner
The I’M WOMAN Trial assess the benefits of intramuscular TXA in Tanzania
The I’M WOMAN Trial team at LSHTM visited Tanzania in October 2024. The trial is collaborating with the University of Dar es Salaam, Tanzania’s National Coordinating Centre for the trial, alongside six regional referral hospitals, two regional hospitals and one national hospital. Dr Amy Brenner, Principal Investigator of the I’M WOMAN Trial at LSHTM, said:
Details
16 pledges from I’M WOMAN Trial clinicians in Tanzania
In October, the I’M WOMAN Trial team exchanged knowledge in Tanzania on the benefits of tranexamic acid (TXA) for severe bleeding in women after childbirth, to prevent maternal deaths. Practising clinicians in obstetrics and gynaecology, including doctors, nurses and midwives involved in recruiting women to the I’M WOMAN Trial, pledged to advocate for the
Details
16 pledges from I’M WOMAN Trial clinicians in Tanzania
In October, the I’M WOMAN Trial team exchanged knowledge in Tanzania on the benefits of tranexamic acid (TXA) for severe bleeding in women after childbirth, to prevent maternal deaths. Practising clinicians in obstetrics and gynaecology, including doctors, nurses and midwives involved in recruiting women to the I’M WOMAN Trial, pledged to advocate for the use
Details